Enhancement of IL-2 and IFN-γ expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo

被引:130
|
作者
Wang, Guan
Zhao, Jian
Liu, Jianwen
Huang, Yongping
Zhong, Jian-Jiang
Tang, Wen
机构
[1] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China
[2] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
[3] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Microbial Metab, Shanghai 200240, Peoples R China
关键词
ganoderic acid Me; NK cells activity; IL-2; IFN-gamma; NF-kappa B; Lewis lung carcinoma;
D O I
10.1016/j.intimp.2007.02.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ganoderic acid Me (GA-Me) is a lanostane triterpenoid purified from Ganoderma lucidum mycelia, one of the most widely used herbs for cancer treatment and prevention in east Asia. In the present study, it was demonstrated that GA-Me could inhibit both tumor growth and lung metastasis of Lewis lung carcinoma in C57BL/6 rnice. Compared with the control group, Natural Killer (NK) cells activity was significantly enhanced by intraperitoneal administration of GA-Me (28 mg/kg). Results of ELISA assay and RT-PCR showed that the expressions of Interleukin-2 (IL-2) and Interferon-gamma (IFN-gamma) were also increased (p<0.05). Additionally, the expression of Nuclear Factor-KB (NF-KB) was up-regulated after the treatment of GA-Me, which might be involved in the production of IL-2. In conclusion, the findings of this study implied that GA-Me could effectively inhibit tumor growth and lung metastasis through increasing immune function. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 50 条
  • [1] NK cells secrete high levels of IFN-γ in response to in vivo administration of IL-2
    Thornton, S
    Kuhn, KA
    Finkelman, FD
    Hirsch, R
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (11) : 3355 - 3360
  • [2] Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells
    Tezuka, Yasuhiro
    Endo, Shunsuke
    Matsui, Aya
    Sato, Atsuko
    Saito, Katsuyo
    Semba, Kentaro
    Takahashi, Masafumi
    Murakami, Takashi
    LUNG CANCER, 2012, 78 (03) : 185 - 192
  • [3] PolyI:C plus IL-2 or IL-12 induce IFN-γ production by human NK cells via autocrine IFN-β
    Duluc, Dorothee
    Tan, Fang
    Scotet, Mari
    Blanchard, Simon
    Fremaux, Isabelle
    Garo, Erwan
    Horvat, Branka
    Eid, Pierre
    Delneste, Yves
    Jeannin, Pascale
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (10) : 2877 - 2884
  • [4] Astragaloside III Enhances Anti-Tumor Response of NK Cells by Elevating NKG2D and IFN-γ
    Chen, Xingmeng
    Chen, Xi
    Gao, Junxiao
    Yang, Han
    Duan, Yue
    Feng, Yuxin
    He, Xin
    Gong, Xiaoqun
    Wang, Hanjie
    Wu, Xiaoli
    Chang, Jin
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [5] IFN-γ Inhibits IL-4-Induced Type 2 Cytokine Expression by CD8 T Cells In Vivo and Modulates the Anti-Tumor Response
    Apte, Simon H.
    Groves, Penny
    Olver, Stuart
    Baz, Adriana
    Doolan, Denise L.
    Kelso, Anne
    Kienzle, Norbert
    JOURNAL OF IMMUNOLOGY, 2010, 185 (02): : 998 - 1004
  • [6] Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells
    Zhao, Lianjing
    Niu, Chao
    Shi, Xiumin
    Xu, Dongsheng
    Li, Min
    Cui, Jiuwei
    Li, Wei
    Xu, Jianting
    Jin, Haofan
    ONCOLOGY LETTERS, 2018, 16 (01) : 1180 - 1188
  • [7] Synergistic effect of IL-4 on IL-2-and IL-12-induction of murine IFN-γ expression in NK cells
    Bream, JH
    Cheng, RY
    Curiel, R
    Grusby, M
    Aune, T
    Young, HA
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 79 - 79
  • [8] Local secretion of IFN-γ induces an antitumor response:: Comparison between T cells plus IL-2 and IFN-γ transfected tumor cells
    Sadanaga, N
    Nagoshi, M
    Lederer, JA
    Joo, HG
    Eberlein, TJ
    Goedegebuure, PS
    JOURNAL OF IMMUNOTHERAPY, 1999, 22 (04): : 315 - 323
  • [9] Anti-tumor effect by dendritic cells stimulated with IL-2 in OT-1 model
    Yang, Qin
    Herberman, Ronald B.
    Lotze, Michael T.
    Kalinski, Pawel
    Basse, Per H.
    FASEB JOURNAL, 2008, 22
  • [10] Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination:: IL-2, IFN-γ, or combination IL-2+IFN-γ
    Kircheis, R
    Kupcu, Z
    Wallner, G
    Wagner, E
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (02) : 95 - 103